연구성과로 돌아가기
JCR 2024 저널 목록 (999 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Urban Science | MDPI | N/A | 2413-8851 | ESCI | ENVIRONMENTAL STUDIES | 1,949 | 2.9 | Q3 | 50.0 | 50.0 | 96/191 | 2.7 | Q3 | 2.6 | 0.5 | 0.70 | 101/191 | Q3 | 47.38 | 0.002 | 0.399 | 0.460 | Q4 | 263 | 89.4% | 3.8 | 6.0 | 235 | 99.8% | 2025-08-05 16:03:14 | 바로가기 |
| WORLD BANK ECONOMIC REVIEW | OXFORD UNIV PRESS | 0258-6770 | 1564-698X | SSCI | BUSINESS, FINANCE | 3,177 | 1.8 | Q3 | 50.0 | 50.0 | 121/241 | 3.2 | Q2 | 1.7 | 0.3 | 0.68 | 81/241 | Q2 | 66.60 | 0.003 | 0.770 | 1.889 | Q1 | 61 | 100.0% | 13.8 | 9.0 | 61 | 27.1% | 2025-08-05 16:02:35 | 바로가기 |
| Advanced Therapeutics | WILEY | N/A | 2366-3987 | SCIE | PHARMACOLOGY & PHARMACY | 2,977 | 2.6 | Q3 | 50.1 | 49.9 | 177/352 | 3.7 | Q2 | 2.5 | 0.5 | 0.77 | 132/353 | Q2 | 62.75 | 0.004 | 0.873 | 0.726 | Q2 | 161 | 69.6% | 4.2 | 6.0 | 112 | 29.6% | 2025-08-05 16:04:34 | 바로가기 |
| CURRENT PHARMACEUTICAL BIOTECHNOLOGY | BENTHAM SCIENCE PUBL LTD | 1389-2010 | 1873-4316 | SCIE | PHARMACOLOGY & PHARMACY | 4,758 | 2.6 | Q3 | 50.1 | 49.9 | 177/352 | 2.4 | Q3 | 2.5 | 0.9 | 0.46 | 251/353 | Q3 | 29.04 | 0.002 | 0.459 | 0.358 | Q3 | 279 | 36.6% | 7.8 | 7.3 | 102 | 0.5% | 2025-08-05 16:04:34 | 바로가기 |
| Fitoterapia | ELSEVIER | 0367-326X | 1873-6971 | SCIE | PHARMACOLOGY & PHARMACY | 12,337 | 2.6 | Q3 | 50.1 | 49.9 | 177/352 | 3.0 | Q2 | 2.4 | 0.6 | 0.69 | 164/353 | Q2 | 53.68 | 0.004 | 0.975 | 0.430 | Q3 | 469 | 86.4% | 9.2 | 7.9 | 405 | 4.3% | 2025-08-05 16:04:33 | 바로가기 |
| INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY | SAGE PUBLICATIONS INC | 0394-6320 | 2058-7384 | SCIE | PHARMACOLOGY & PHARMACY | 3,105 | 2.6 | Q3 | 50.1 | 49.9 | 177/352 | 3.0 | Q2 | 2.6 | 0.5 | 0.83 | 110/353 | Q2 | 68.98 | 0.002 | 0.379 | 0.593 | Q3 | 75 | 97.3% | 8.5 | 6.0 | 73 | 94.5% | 2025-08-05 16:04:34 | 바로가기 |
| Asian Business & Management | PALGRAVE MACMILLAN LTD | 1472-4782 | 1476-9328 | SSCI | BUSINESS | 908 | 2.8 | Q3 | 50.2 | 49.8 | 159/316 | 3.2 | Q3 | 2.5 | 1.3 | 0.50 | 186/317 | Q3 | 41.48 | 0.001 | 0.169 | 0.516 | Q3 | 23 | 91.3% | 4.5 | 10.2 | 21 | 13.8% | 2025-08-05 16:02:36 | 바로가기 |
| FIIB Business Review | SAGE PUBLICATIONS INDIA PVT LTD | 2319-7145 | 2455-2658 | ESCI | BUSINESS | 911 | 2.8 | Q3 | 50.2 | 49.8 | 159/316 | 2.5 | Q3 | 2.6 | 0.8 | 0.61 | 156/317 | Q2 | 50.95 | 0.001 | 0.190 | 0.340 | Q3 | 43 | 93.0% | 2.5 | 6.2 | 40 | 2.1% | 2025-08-05 16:02:36 | 바로가기 |
| Journal of International Consumer Marketing | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 0896-1530 | 1528-7068 | ESCI | BUSINESS | 1,461 | 2.8 | Q3 | 50.2 | 49.8 | 159/316 | 3.2 | Q3 | 2.6 | 0.5 | 0.41 | 204/317 | Q3 | 35.80 | 0.001 | 0.153 | 0.483 | Q3 | 28 | 100.0% | 7.9 | 7.3 | 28 | 15.2% | 2025-08-05 16:02:36 | 바로가기 |
| Marketing Theory | SAGE PUBLICATIONS INC | 1470-5931 | 1741-301X | SSCI | BUSINESS | 2,300 | 2.8 | Q3 | 50.2 | 49.8 | 159/316 | 3.4 | Q2 | 2.3 | 0.5 | 0.59 | 165/317 | Q3 | 48.11 | 0.001 | 0.315 | 1.055 | Q2 | 31 | 100.0% | 10.9 | 10.9 | 31 | 56.5% | 2025-08-05 16:02:36 | 바로가기 |
| Measuring Business Excellence | EMERALD GROUP PUBLISHING LTD | 1368-3047 | 1758-8057 | ESCI | BUSINESS | 1,150 | 2.8 | Q3 | 50.2 | 49.8 | 159/316 | 3.4 | Q2 | 2.6 | 0.4 | 0.54 | 177/317 | Q3 | 44.32 | 0.001 | 0.132 | 0.451 | Q3 | 37 | 100.0% | 5.9 | 6.4 | 37 | 12.8% | 2025-08-05 16:02:36 | 바로가기 |
| Bioresource Technology Reports | ELSEVIER | 2589-014X | 2589-014X | ESCI | ENERGY & FUELS | 6,649 | 4.3 | Q3 | 50.3 | 49.7 | 92/182 | N/A | N/A | 4.2 | 1.7 | 0.83 | 77/182 | Q2 | 57.97 | 0.007 | 1.488 | N/A | N/A | 304 | 95.1% | 2.7 | 5.7 | 289 | 12.8% | 2025-08-05 16:03:04 | 바로가기 |
| Energy Advances | ROYAL SOC CHEMISTRY | N/A | 2753-1457 | ESCI | ENERGY & FUELS | 1,403 | 4.3 | Q3 | 50.3 | 49.7 | 92/182 | 4.3 | Q3 | 4.2 | 1.1 | 0.58 | 104/182 | Q3 | 43.13 | 0.002 | 0.362 | 0.763 | Q3 | 212 | 83.0% | 1.6 | 5.8 | 176 | 99.8% | 2025-08-05 16:03:04 | 바로가기 |
| ANNALS OF NUTRITION AND METABOLISM | KARGER | 0250-6807 | 1421-9697 | SCIE | NUTRITION & DIETETICS | 5,027 | 2.9 | Q3 | 50.4 | 49.6 | 57/112 | 4.8 | Q2 | 2.8 | 0.4 | 0.61 | 59/112 | Q3 | 47.77 | 0.003 | 0.577 | 1.224 | Q1 | 42 | 88.1% | 9.2 | 8.0 | 37 | 36.7% | 2025-08-05 16:04:22 | 바로가기 |
| Bioscience of Microbiota Food and Health | BMFH PRESS | 2186-6953 | 2186-3342 | SCIE | NUTRITION & DIETETICS | 770 | 2.9 | Q3 | 50.4 | 49.6 | 57/112 | 3.5 | Q2 | 2.8 | 0.5 | 0.74 | 45/112 | Q2 | 60.27 | 0.001 | 0.164 | 0.700 | Q3 | 44 | 77.3% | 4.8 | 7.5 | 34 | 99.0% | 2025-08-05 16:04:22 | 바로가기 |
페이지 이동: